Clinical Trial Update: Cilostazol for Prevention of Recurrent Stroke Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cilostazol for prevention of recurrent stroke; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Cilostazol (Cilostazol)
• Pletal (cilostazol)

Snippet

Sponsor: Stanford University | Conditions: Stroke Recurrence, Myocardial Infarction | Phase 3 | Status: NOT_YET_RECRUITING